Unique ID issued by UMIN | UMIN000029031 |
---|---|
Receipt number | R000033205 |
Scientific Title | Randomized controlled trial of a comprehensive cognitive training program for stress-related symptoms |
Date of disclosure of the study information | 2018/04/01 |
Last modified on | 2024/12/02 13:35:25 |
Randomized controlled trial of a comprehensive cognitive training program for stress-related symptoms
Randomized controlled trial of a comprehensive cognitive training program for stress-related symptoms
Randomized controlled trial of a comprehensive cognitive training program for stress-related symptoms
Randomized controlled trial of a comprehensive cognitive training program for stress-related symptoms
Japan |
High anxious/depressive adults
Adult |
Others
NO
To examine the efficacy and action mechanisms of a memory-targeted cognitive training program on stress-related traits and symptoms in highly anxious/depressive adults using psychological/behavioral assessment and neuroimaging
Efficacy
Anxiety and depressive personality traits
Stress-related symptoms including anxiety and depression, memory biases, and stress hormone cortisol
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Educational,Counseling,Training
Behavior,custom | Other |
cognitive bias modification program (8 sessions/month)
non-cognitive bias modification program (8 sessions/month)
18 | years-old | <= |
60 | years-old | > |
Male and Female
Participants who score 1SD or more on a neurotic personality-related trait questionnaire.
The following participants are excluded:
(1) those who have current Axis-I psychiatric disorders or substance-abuse history as determined by a structured clinical interview, (2) major medical illnesses including neurological diseases, (3) metal embedded in the body or medical appliance attached to the body, (4) history of brain injury or trauma with loss of consciousness over 10 minutes or more, (5) regular use of cold medicine, (6) excessive intake of caffeine or tobacco, (7) regular intake of psychotropics, steroids, or opioids within the previous 30 days or during the study period, and (8) those who received psychotherapy or counselling within the previous 30 days or will receive either of them during the study period.
212
1st name | Hirokuni |
Middle name | |
Last name | Tagaya |
Kitasato University
Department of Health Sciences
252-0329
1-15-1, Kitasato, Minami-ku, Sagamihara, Kanagawa, Japan
042-778-7909
tagaya@kitasato-u.ac.jp
1st name | Yuko |
Middle name | |
Last name | Hakamata |
National Center of Neurology and Psychiatry
National Institute of Mental Health
187-8553
4-1-1, Ogawahigashi, Kodaira, Tokyo, Japan.
042-346-1986
hakamatay@ncnp.go.jp
Kitasato University
Japan Society for the Promotion of Science
Japanese Governmental office
Kitasato University Hospital
Kitasato 1-15-1, Minami-ku, Sagamihara, Kanagawa
042-778-8273
rinrib@med.kitasato-u.ac.jp
NO
2018 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2018 | Year | 01 | Month | 01 | Day |
2017 | Year | 10 | Month | 25 | Day |
2020 | Year | 08 | Month | 01 | Day |
2026 | Year | 08 | Month | 31 | Day |
2017 | Year | 09 | Month | 06 | Day |
2024 | Year | 12 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033205